Cross-sectional prevalence of metabolic syndrome in Korean patients with schizophrenia

Schizophrenia Research

Volumn 128, Issue 1-3, 2011, Pages 179-181

  Kang, Shi Hyun ^a   Kim, Kyoung Hoon ^a   Kang, Gwon Young ^a   Lee, Ka Hee ^b   Kim, Kwon Kon ^c   Soh, Minah ^c   Ahn, Kil Joon ^a   Kim, Seok Hyeon ^d   Lee, Jong il ^a  

^a Seoul National University Hospital   (South Korea)

^b West Suwon Hospital   (South Korea)

^c Ansan Psychiatry Clinic   (South Korea)

^d Hanyang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NEUROLEPTIC AGENT; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRY; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; HYPERTENSION; KOREA; LETTER; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 79955485210     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.12.014     Document Type: Letter

References (16)

1. Brown L.M., Clegg D.J. Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J. Steroid Biochem. Mol. Biol. 2010, 122:65-73.
2. Cameron A.J., Shaw J.E., Zimmet P.Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab. Clin. North Am. 2004, 33:351-376.
3. De Hert M., Schreurs V., et al. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 2009, 8(1):15-22.
4. De Hert M.A., Van Winkel R., Van Eyck D., Hanssens L., Wampers M., Scheen A., Peuskens J. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr. Res. 2006, 83:87-93.
5. Fujimoto W.Y., Bergstrom R.W., Boyko E.J., Chen K.W., Kahn S.E., Leonetti D.L., McNeely M.J., Newell L.L., Shofer J.B., Wahl P.W. Type 2 diabetes and the metabolic syndrome in Japanese Americans. Diab. Res. Clin. Pract. 2000, 50:S73-S76.
6. Graham K.A., Perkins D.O., Edwards L.J., Barrier R.C., Lieberman J.A., Harp J.B. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis. Am. J. Psychiatry 2005, 162:118-123.
7. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005, 112:2735-2752.
8. Hagg S., Lindblom Y., Mjorndal T., Adolfsson R. High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia. Int. Clin. Psychopharmacol. 2006, 21:93-98.
9. Kannel W.B. Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure. Cardiovasc. Drugs Ther. 1997, 11:199-212.
10. McEvoy J.P., Meyer J.M., Goff D.C., Nasrallah H.A., Davis S.M., Sullivan L., Meltzer H.Y., Hsiao J., Scott Stroup T. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr. Res. 2005, 80:19-32.
11. Park H.S., Kim S.M., Lee J.S., Lee J., Han J.H., Yoon D.K., Baik S.H., Choi D.S., Choi K.M. Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998-2001. Diab. Obes. Metab. 2007, 9:50-58.
12. Park H.S., Park C.Y., Oh S.W., Yoo H.J. Prevalence of obesity and metabolic syndrome in Korean adults. Obes. Rev. 2008, 9:104-107.
13. Ryan M., Flanagan S., Kinsella U., Keeling F., Thakore J.H. The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. Life Sci. 2004, 74:1999-2008.
14. Sugawara N., Yasui-Furukori N., et al. Prevalence of metabolic syndrome among patients with schizophrenia in Japan. Schizophr. Res. 2010, 123:244-250.
15. Williams C.M. Lipid metabolism in women. Proc. Nutr. Soc. 2004, 63(01):153-160.
16. Wolf-Maier K., Cooper R.S., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003, 289(18):2363-2369.